Predictive markers of response to ICIs include tumour-intrinsic parameters such as tumour mutational burden, microsatellite instability, baseline tumour cell PD-L1 expression, and the presence of tumour-infiltrating lymphocytes [1]. The gene discussed is CD274; the disease is neoplasm.